John J. Cush

10.8k citations

59 papers · 4.3k indexed · 2 hit papers · h-index 31

Impact in

Rheumatology top 0.2%
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Spondyloarthritis Studies and Treatments
Hematology top 0.5%
- Autoimmune and Inflammatory Disorders Research

Papers in

Rheumatology 36
- Rheumatoid Arthritis Research and Therapies 32
- Systemic Lupus Erythematosus Research 19
Hematology 22
- Autoimmune and Inflammatory Disorders Research 20

Co-authors: Peter E. Lipsky Roy Fleischmann Joel M. Kremer Hendrik Schulze‐Koops Carol A. Connell Keith S. Kanik David Gruben Samuel H. Zwillich
Journals: Rheumatic Disease Clinics of North America (7 papers)The Journal of Rheumatology (4 papers)The American Journal of Medicine (3 papers)Arthritis Care & Research (3 papers)Gastroenterology (2 papers)
Partner nations: United States Canada Switzerland

In The Last Decade

John J. Cush

58 papers receiving 4.1k citations

Hit Papers

align trajectories log scale

Placebo-Controlled Trial of Tofacitinib Monotherapy in Rheumatoid Arthritis 2012 · 790 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2012 New England Journal of Medicine
2003 Arthritis & Rheumatism

Peers

Countries citing papers authored by John J. Cush

Since Specialization

Citations

This map shows the geographic impact of John J. Cush's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John J. Cush with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John J. Cush more than expected).

Fields of papers citing papers by John J. Cush

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John J. Cush. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John J. Cush. The network helps show where John J. Cush may publish in the future.

Co-authorship network

The 25 scholars most cited alongside John J. Cush, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John J. Cush Line = papers co-authored together John J. Cush links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Home‐Based Telemedicine in Rheumatology—A Scoping Review ACR Open Rheumatology ·Swamy Venuturupalli, R N Yadawad, Mi Sook Kang, Tassiane Aparecida Ferreira Valin, Yuhao Zhao, W. Benjamin Nowell, Kelly Gavigan, John J. Cush, Neelkamal Soares, Rebecca Grainger, Jeffrey R. Curtis	2024	1
2	Rheumatoid Arthritis Rheumatic Disease Clinics of North America ·John J. Cush	2022	78
3	Assessing rheumatologists’ attitudes and utilization of classification criteria for ankylosing spondylitis and axial spondyloarthritis: a global effort Clinical Rheumatology ·Luanna dos Santos Rocha, Abhijeet Danve, Dongseok Choi, K. Charankumar, Nurullah Akkoç, Mojca Indihar Šternberger, Anthony S. Russell, Aman Sharma, John J. Cush, パトリシアガルシア, Atul Deodhar	2020	11
4	FRI0171 CLINICAL RESPONSES IN PATIENTS WITH INADEQUATE RESPONSE TO BDMARDS UPON TREATMENT WITH UPADACITINIB Annals of the Rheumatic Diseases ·Michael E. Weinblatt, G. T. D. Thomson, Kun Chen, Sebastian Meerwein, Marcus Graetsch, John J. Cush	2019	2
5	Routine Use of Quantitative Disease Activity Measurements among US Rheumatologists: Implications for Treat-to-target Management Strategies in Rheumatoid Arthritis The Journal of Rheumatology ·Jeffrey R. Curtis, Lang Chen, Maria I. Danila, Kenneth G. Saag, Janneth Chicaiza, John J. Cush	2017	31
6	Malignancy Risks With Biologic Therapies Rheumatic Disease Clinics of North America ·John J. Cush, Kathryn H. Dao	2012	16
7	Comprehensive tuberculosis screening program in patients with inflammatory arthritides treated with golimumab, a human anti–tumor necrosis factor antibody, in Phase III clinical trials Arthritis Care & Research ·Elizabeth C. Hsia, John J. Cush, Eric L. Matteson, Anna Beutler, Mittie K. Doyle, Benjamin Hsu, Stephen Xu, Mahboob U. Rahman	2012	48
8	Interferon‐γ release assay versus tuberculin skin test prior to treatment with golimumab, a human anti–tumor necrosis factor antibody, in patients with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis Arthritis & Rheumatism ·Elizabeth C. Hsia, Neil W. Schluger, John J. Cush, Richard E. Chaisson, Eric L. Matteson, Stephen Xu, Anna Beutler, Mittie K. Doyle, Benjamin Hsu, Mahboob U. Rahman	2012	62
9	Tocilizumab as monotherapy or in combination with nonbiologic disease‐modifying antirheumatic drugs: Twenty‐four–week results of an open‐label, clinical practice study Arthritis Care & Research ·Michael E. Weinblatt, Joel Kremer, John J. Cush, William F. C. Rigby, Lichen Teng, Jenny Devenport, Natasha Singh, Denise Lepley, Mark C. Genovese	2012	51
10	Can Tumor Necrosis Factor Inhibitors Be Safely Used in Pregnancy? The Journal of Rheumatology ·Yaser Ali, Bindee Kuriya, Trenton House, John J. Cush, Edward Keystone	2009	30
11	Iatrogenic Rheumatic Syndromes in the Elderly Rheumatic Disease Clinics of North America ·南雲民人, John J. Cush	2007	3
12	Unusual toxicities with TNF inhibition: heart failure and drug-induced lupus. PubMed ·John J. Cush, (unknown), (unknown), (unknown), (unknown), (unknown)	2004	40
13	Safety of new biologic therapies in rheumatoid arthritis John J. Cush	2003	2
14	Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin‐1 receptor antagonist, in combination with methotrexate: Results of a twenty‐four–week, multicenter, randomized, double‐blind, placebo‐controlled trial Arthritis & Rheumatism ·Stanley Cohen, Eric R. Hurd, John J. Cush, Michael Schiff, Michael E. Weinblatt, Larry W. Moreland, Joel M. Kremer, Moraye B. Bear, William Rich, Dorothy McCabe	2002	499
15	US consensus guidelines for the use of cyclosporin A in rheumatoid arthritis. PubMed ·John J. Cush, Peter Tugwell, Michael E. Weinblatt, David E. Yocum	1999	30
16	An evidence-based medicine approach to the diagnosis and management of musculoskeletal complaints The American Journal of Medicine ·A. Ellrodt, Magdalena Trojak, John J. Cush, Arthur F. Kavanaugh, Peter E. Lipsky	1997	8
17	A double‐blind, placebo‐controlled study of anti‐CD5 immunoconjugate in patients with rheumatoid arthritis Arthritis & Rheumatism ·Nancy J. Olsen, Raye H. Brooks, John J. Cush, Peter E. Lipsky, E. William St. Clair, Eric L. Matteson, Kenneth N. Gold, Grant W. Cannon, Christopher Jackson, W. Joseph McCune, Betty J Nelson, Todd J. Lorenz, Vibeke Strand	1996	33
18	Elevated interleukin-10 levels in patients with rheumatoid arthritis Arthritis & Rheumatism ·John J. Cush, Judy Splawski, Ranjeny Thomas, Jackie McFarlin, Hendrik Schulze‐Koops, Laurie S. Davis, Kenji Fujita, Peter E. Lipsky	1995	218
19	Increased levels of circulating intercellular adhesion molecule 1 in the sera of patients with rheumatoid arthritis Arthritis & Rheumatism ·John J. Cush, Robert Rothlein, Herbert B. Lindsley, Elizabeth A. Mainolfi, Peter E. Lipsky	1993	85
20	The intrinsic migratory capacity of memory T cells contributes to their accumulation in rheumatoid synovium Arthritis & Rheumatism ·John J. Cush, Peter Pietschmann, Nancy Oppenheimer‐Marks, Peter E. Lipsky	1992	54

About John J. Cush

John J. Cush is a scholar working on Rheumatology, Hematology, Immunology, Genetics and Radiology, Nuclear Medicine and Imaging, having authored 59 papers that have together received 4.3k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (32 papers), Autoimmune and Inflammatory Disorders Research (20 papers), Systemic Lupus Erythematosus Research (19 papers), Monoclonal and Polyclonal Antibodies Research (10 papers), Pregnancy and Medication Impact (8 papers), Reproductive System and Pregnancy (7 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Eosinophilic Esophagitis (5 papers). The work is most often cited by research in Rheumatology (2.5k citations), Hematology (1.2k citations), Immunology (1.6k citations), Genetics (399 citations) and Immunology and Allergy (194 citations). John J. Cush has collaborated with scholars based in United States, Canada and Switzerland. Frequent co-authors include Peter E. Lipsky, Roy Fleischmann, Joel M. Kremer, Hendrik Schulze‐Koops, Carol A. Connell, Keith S. Kanik, David Gruben, Samuel H. Zwillich, Gene V. Wallenstein and John Bradley. Their work appears in journals such as Rheumatic Disease Clinics of North America, The Journal of Rheumatology, The American Journal of Medicine, Arthritis Care & Research and Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact